Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 16 of 16 publications.

Halperin JL, Rothman K. Initial antithrombotic therapy after percutaneous left atrial appendage occlusion: shifting approaches to a moving target. J Am Coll Cardiol. 2023 Oct 31;82(18):1774-6. doi: 10.1016/j.jacc.2023.08.037

Casas G, Limeres J, Oristrell G, Gutierrez-Garcia L, Andreini D, Borregan M, Larrañaga-Moreira JM, Lopez-Sainz A, Codina-Solà M, Teixido-Tura G, Sorolla-Romero JA, Fernández-Álvarez P, González-Carrillo J, Guala A, La Mura L, Soler-Fernández R, Sao Avilés A, Santos-Mateo JJ, Marsal JR, Ribera A, de la Pompa JL, Villacorta E, Jiménez-Jáimez J, Ripoll-Vera T, Bayes-Genis A, Garcia-Pinilla JM, Palomino-Doza J, Tiron C, Pontone G, Bogaert J, Aquaro GD, Gimeno-Blanes JR, Zorio E, Garcia-Pavia P, Barriales-Villa R, Evangelista A, Masci PG, Ferreira-González I, Rodríguez-Palomares JF. Clinical risk prediction in patients with left ventricular myocardial noncompaction. J Am Coll Cardiol. 2021 Aug 17;78(7):643-62. doi: 10.1016/j.jacc.2021.06.016

Dong OM, Friede K, Chanfreau C, Voora D. One-year cost-effectiveness of CYP2C19- guided de-escalation and escalation of P2Y12 inhibitors in veterans with acute coronary syndromes undergoing percutaneous coronary intervention. Presented at the American College of Cardiology’s Virtual 70th Annual Scientific Session and Exposition; May 15, 2021. [abstract] J Am Coll Cardiol. 2021 May; 77(18 Suppl 1):3416.

Ajmera MR, Boscoe A, Mauskopf J, Candrilli SD, Levy M. Evaluation of comorbidities and health care resource use among patients with highly active neuromyelitis optica. J Neurol Sci. 2018 Jan;384(2018):96-103. doi: 10.1016/j.jns.2017.11.022

Paquette M, Riou Franca L, Teutsch C, Diener HC, Lu S, Dubner SJ, Ma CS, Rothman KJ, Zint K, Halperin JL, Huisman MV, Lip GYH, Nieuwlaat R. Persistence with dabigatran therapy at 2 years in patients with atrial fibrillation. J Am Coll Cardiol. 2017 Sep 26;70(13):1573-83. doi: 10.1016/j.jacc.2017.07.793

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY, GLORIA-AF Investigators. The changing landscape for stroke prevention in AF: findings from the GLORIA-AF Registry Phase 2. J Am Coll Cardiol. 2017 Feb 21;69(7):777-85.

Garcia-Albeniz X, Hsu J, Lipsitch M, Bretthauer M, Logan RW, Hernandez-Diaz S, Hernan MA. Colonoscopy and risk of infective endocarditis in the elderly. J Am Coll Cardiol. 2016 Aug 2;68(5):570-1. doi: 10.1016/j.jacc.2016.05.041

Archer R, Tappenden P, Ren S, Martyn-St James M, Harvey R, Basarir H, Stevens J, Carroll C, Cantrell A, Lobo A, Hoque S. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technol Assess. 2016 May;20(39):1-326. doi: 10.3310/hta20390

Olson J, Sharp P, Goatman K, Prescott G, Scotland G, Fleming A, Philip S, Santiago C, Borooah S, Broadbent D, Chong V, Dodson P, Harding S, Leese G, Styles C, Swa K, Wharton H. Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol Assess. 2013 Nov 1;17(51):1-142. doi: 10.3310/hta17510

Ferreira-Gonzalez I, Marsal JR, Ribera A, Permanyer-Miralda G, Garcia-Del Blanco B, Marti G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martin E, Serra A, Rumoroso JR, Ruiz-Salmeron R, De La Torre JM, Cequier A, Gomez-Hospital JA, Alfonso F, Martin-Yuste V, Sabate M, Garcia-Dorado D. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9. doi: 10.1016/j.jacc.2012.04.057

Jacquemin B, Antoniades C, Nyberg F, Plana E, Muller M, Greven S. Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol. 2008 Sep 9;52(11):941-52.

Njue AI, Prichard RK. Efficacy of ivermectin in calves against a resistant Cooperia oncophora field isolate. Parasitol Res. 2004 Aug 1;93(5):419-22.

Anthony MS, Clarkson TB. Does extent of pretreatment atherosclerosis influence the effects of conjugated equine estrogens on atherosclerosis progression? Presented at the 51st Annual Scientific Session of the American College of Cardiology; March 17, 2002. Atlanta, GA. [abstract] J Am Coll Cardiol. 2002 Mar; 39:248A.

Palka P, Lange A, Fleming AD, Donnelly JE, Dutka DP, Starkey IR, Shaw TR, Sutherland GR, Fox KA. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol. 1997 Sep 1;30(3):760-8. doi: 10.1016/s0735-1097(97)00231-3

Palka P, Lange A, Fleming AD, Fenn LN, Shaw TRD, Starkey IR, Fox KAA, McDicken WN, Sutherland GR. Assessment of transmural velocity gradients in hypertrophic hearts-A new diagnostic index for hypetrophic cardiomyopathy. J Am Coll Cardiol. 1996 Feb 1;27(2_supplement_1):21.

Williams VSL, Wakeford ME. The predictive validity of the National Teacher Examinations for performance in teacher education programs. Educ Psychol Meas. 1993;53(2):533-9. doi: 10.1177/0013164493053002023